HEYL and pachyonychia congenita: Finally, we found a favorable Notch signature among 6 (27.3%) late-stage PC patients aged above 70 years old, consisting of JAG1, PTCRA, HEYL, DTX3, and RFNG (HR < 0.001, p = 0.013, Figure 2).